|
1
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Garzon R, Marcucci G and Croce CM:
Targeting microRNAs in cancer: Rationale, strategies and
challenges. Nat Rev Drug Discov. 9:775–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carthew RW and Sontheimer EJ: Origins and
mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iorio MV and Croce CM: microRNA
involvement in human cancer. Carcinogenesis. 33:1126–1133. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Santovito D, Mezzetti A and Cipollone F:
MicroRNAs and atherosclerosis: New actors for an old movie. Nutr
Metab Cardiovasc Dis. 22:937–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou H, Wang K, Hu Z and Wen J: The effect
of miR-193b on the metastatic and invasive capacity of gastric
cancer cells. Chin J Gen Surg. 20:377–382. 2011.
|
|
7
|
Tang H, Liu X, Wang Z, She X, Zeng X, Deng
M, Liao Q, Guo X, Wang R, Li X, et al: Interaction of hsa-miR-381
and glioma suppressor LRRC4 is involved in glioma growth. Brain
Res. 1390:21–32. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xiong X and Zheng CL: The effect of
miRNA-214 on cell cycle and apoptosis of gastric cancer cell lines
BGC823 and MKN45. Chin J Gen Surg. 19:1311–1315. 2010.
|
|
9
|
Zhang L, Deng T, Li X, Liu H, Zhou H, Ma
J, Wu M, Zhou M, Shen S, Li X, et al: microRNA-141 is involved in a
nasopharyngeal carcinoma-related genes network. Carcinogenesis.
31:559–566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J, Han C and Wu T: MicroRNA-26a
promotes cholangiocarcinoma growth by activating β-catenin.
Gastroenterology. 143:246–56.e8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Frampton AE, Castellano L, Colombo T,
Giovannetti E, Krell J, Jacob J, Pellegrino L, Roca-Alonso L, Funel
N, Gall TM, et al: MicroRNAs cooperatively inhibit a network of
tumor suppressor genes to promote pancreatic tumor growth and
progression. Gastroenterology. 146:268–277. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mir MR, Shabir N, Wani KA, Shaff S,
Hussain I, Banday MA, Chikan NA, Bilal S and Aejaz S: Association
between p16, hMLH1 and E-cadherin promoter hypermethylation and
intake of local hot salted tea and sun-dried foods in Kashmiris
with gastric tumors. Asian Pac J Cancer Prev. 13:181–186. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen L, Yan Y, Zhu L, Cong X, Li S, Song
S, Song H and Xue Y: Systemic immune-inflammation index as a useful
prognostic indicator predicts survival in patients with advanced
gastric cancer treated with neoadjuvant chemotherapy. Cancer Manag
Res. 9:849–867. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu LH, Liu T, Tang H, Tian RQ, Su C, Liu
M and Li X: MicroRNA-23a promotes the growth of gastric
adenocarcinoma cell line MGC803 and downregulates interleukin-6
receptor. FEBS J. 277:3726–3734. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu T, Tang H, Lang Y, Liu M and Li X:
MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by
targeting prohibitin. Cancer Lett. 273:233–242. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Evans CA, Tonge R, Blinco D, Pierce A,
Shaw J, Lu Y, Hamzah HG, Gray A, Downes CP, Gaskell SJ, et al:
Comparative proteomics of primitive hematopoietic cell populations
reveals differences in expression of proteins regulating motility.
Blood. 103:3751–3759. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gardner PP, Daub J, Tate JG, Nawrocki EP,
Kolbe DL, Lindgreen S, Wilkinson AC, Finn RD, Griffiths-Jones S,
Eddy SR, et al: Rfam: Updates to the RNA families database. Nucleic
Acids Res. 37:D136–D140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nikolic I, Elsworth B, Dodson E, Wu SZ,
Gould CM, Mestdagh P, Marshall GM, Horvath LG, Simpson KJ and
Swarbrick A: Discovering cancer vulnerabilities using
high-throughput micro-RNA screening. Nucleic Acids Res.
45:12657–12670. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Creemers EE, Tijsen AJ and Pinto YM:
Circulating microRNAs: Novel biomarkers and extracellular
communicators in cardiovascular disease? Circ Res. 110:483–495.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Topkara VK and Mann DL: Role of microRNAs
in cardiac remodeling and heart failure. Cardiovasc Drugs Ther.
25:171–182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Divakaran V and Mann DL: The emerging role
of microRNAs in cardiac remodeling and heart failure. Circ Res.
103:1072–1083. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993.
|
|
23
|
Ambros V: microRNAs: Tiny regulators with
great potential. Cell. 107:823–826. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guay C, Roggli E, Nesca V, Jacovetti C and
Regazzi R: Diabetes mellitus, a microRNA-related disease? Transl
Res. 157:253–264. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kerr TA, Korenblat KM and Davidson NO:
MicroRNAs and liver disease. Transl Res. 157:241–252. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dai R and Ahmed SA: MicroRNA, a new
paradigm for understanding immunoregulation, inflammation, and
autoimmune diseases. Transl Res. 157:163–179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Small EM and Olson EN: Pervasive roles of
microRNAs in cardiovascular biology. Nature. 469:336–342. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Olde Loohuis NF, Kos A, Martens GJ, van
Bokhoven H, Nadif Kasri N and Aschrafi A: MicroRNA networks direct
neuronal development and plasticity. Cell Mol Life Sci. 69:89–102.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang S, He X, Ding J, Liang L, Zhao Y,
Zhang Z, Yao X, Pan Z, Zhang P, Li J, et al: Upregulation of
miR-23a approximately 27a approximately 24 decreases transforming
growth factor-beta-induced tumor-suppressive activities in human
hepatocellular carcinoma cells. Int J Cancer. 123:972–978. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ji Q, Hao X, Meng Y, Zhang M, Desano J,
Fan D and Xu L: Restoration of tumor suppressor miR-34 inhibits
human p53-mutant gastric cancer tumorspheres. BMC Cancer.
8:2662008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nishida N, Mimori K, Fabbri M, Yokobori T,
Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y and Mori M:
MicroRNA-125a-5p is an independent prognostic factor in gastric
cancer and inhibits the proliferation of human gastric cancer cells
in combination with trastuzumab. Clin Cancer Res. 17:2725–2733.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang X, Zhu W, Zhang J, Huo S, Zhou L, Gu
Z and Zhang M: MicroRNA-650 targets ING4 to promote gastric cancer
tumorigenicity. Biochem Biophys Res Commun. 395:275–280. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pan J, Hu H, Zhou Z, Sun L, Peng L, Yu L,
Sun L, Liu J, Yang Z and Ran Y: Tumor-suppressive mir-663 gene
induces mitotic catastrophe growth arrest in human gastric cancer
cells. Oncol Rep. 24:105–112. 2010.PubMed/NCBI
|
|
34
|
Shin VY, Jin H, Ng EK, Cheng AS, Chong WW,
Wong CY, Leung WK, Sung JJ and Chu KM: NF-κB targets miR-16 and
miR-21 in gastric cancer: involvement of prostaglandin E receptors.
Carcinogenesis. 32:240–245. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wan HY, Guo LM, Liu T, Liu M, Li X and
Tang H: Regulation of the transcription factor NF-kappaB1 by
microRNA-9 in human gastric adenocarcinoma. Mol Cancer. 9:162010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lang N, Liu M, Tang QL, Chen X, Liu Z and
Bi F: Effects of microRNA-29 family members on proliferation and
invasion of gastric cancer cell lines. Chin J Cancer. 29:603–610.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhi QM, Guo X, Guo L, Zhang R, Jiang J, Ji
J, Zhang J, Zhang J, Chen X, Cai Q, et al: Oncogenic miR-544 is an
important molecular target in gastric cancer. Anticancer Agents Med
Chem. 13:270–275. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li J, Guo Y, Liang X, Sun M, Wang G, De W
and Wu W: MicroRNA-223 functions as an oncogene in human gastric
cancer by targeting FBXW7/hCdc4. J Cancer Res Clin Oncol.
138:763–774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kurashige J, Kurashige J, Kamohara H,
Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y, Kinoshita K, Saito S,
Baba Y and Baba H: MicroRNA-200b regulates cell proliferation,
invasion, and migration by directly targeting ZEB2 in gastric
carcinoma. Ann Surg Oncol. 19(Suppl 3): S656–S664. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou R, O'Hara SP and Chen XM: MicroRNA
regulation of innate immune responses in epithelial cells. Cell Mol
Immunol. 8:371–379. 2011. View Article : Google Scholar : PubMed/NCBI
|
